MET and head and neck squamous cell carcinoma: Consistently, genetic knockdown of c-Met reduced PLXDC2 levels in radioresistant and parental CAL27 cells (Fig. 6D), suggesting blocking c-Met signaling suppresses PLXDC2 expression in HNSCC cells.